Lyft Inc
Change company Symbol lookup
Select an option...
LYFT Lyft Inc
AROC Archrock Inc
PACK Ranpak Holdings Corp
NVEE NV5 Global Inc
YARIY Yara International ASA
HYB New America High Income Fund
ACV Virtus Diversified Income & Convertible Fund
XLO Xilio Therapeutics Inc
ORN Orion Group Holdings Inc
SMHI SEACOR Marine Holdings Inc

Industrials : Road & Rail | Small Cap Value
Company profile

Lyft, Inc. owns and operates multimodal transportation networks in the United States and Canada that offer access to a variety of transportation options through its platform and mobile-based applications. The Lyft Platform provides a marketplace where drivers are matched with riders via the Lyft App. Transportation options through the Company's platform and mobile-based applications are comprised of its ridesharing marketplace that connects drivers and riders in cities across the United States and Canada; Lyft's network of Light Vehicles; the Express Drive program, where drivers can enter into short-term rental agreements with Flexdrive or a third party for vehicles is used to provide ridesharing services, and Lyft Rentals, a consumer offering for users who want to rent a car for a fixed period of time for personal use, and Lyft Driver Centers and Lyft Auto Care, where drivers and riders can request auto maintenance and collision repair services offered through the Lyft Platform.

Closing Price
Day's Change
0.46 (2.90%)
B/A Size
Day's High
Day's Low

10-day average volume:

Regeneron Pharmaceuticals Inc. Stock Rises Tuesday, Outperforms Market

5:18 pm ET May 3, 2022 (MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) rose 1.30% to $660.49 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.48% to 4,175.48 and the Dow Jones Industrial Average rising 0.20% to 33,128.79. The stock's rise snapped a two-day losing streak. Regeneron Pharmaceuticals Inc. closed $86.93 below its 52-week high ($747.42), which the company achieved on April 8th.

The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.20% to $178.29, Novartis AG ADR (NOVN.EB) fell 0.19% to $87.48, and Amgen Inc. (AMGN) rose 0.55% to $232.19. Trading volume (538,564) remained 103,510 below its 50-day average volume of 642,074.

Data source: Dow Jones Market Data, FactSet. Data compiled May 3, 2022.

-MarketWatch Automation


(END) Dow Jones Newswires

May 03, 2022 17:18 ET (21:18 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.